Literature DB >> 7994706

Titers to Leptospira species in horses in Alberta.

V W Lees1, S P Gale.   

Abstract

Sera from horses in Alberta, submitted to Agriculture and Agri-Food Canada for routine testing for equine infectious anemia from January 1987 to June 1989, were tested for antibody against 13 serovars of pathogenic Leptospira spp., using the microscopic agglutination test. The purpose of the study was to investigate the prevalence of serum titers to those serovars in horses in Alberta, and to analyze the associated risk factors. Descriptive statistics were compiled and logistic regressions were computed. Titers to L. interrogans serovars icterohaemorrhagiae, bratislava, copenhageni, and autumnalis were common (94.6%, 56.6%, 46.5%, and 43.5%, respectively). The prevalence of titers to other serovars ranged from 0.8% to 27.2%. Age was almost always significantly associated with the presence of titers. In general, the chances of being seropositive rose by approximately 10% with each year of life. Horses managed individually (eg, track horses) were approximately half as likely to be seropositive as were horses managed in groups (eg, rodeo horses).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7994706      PMCID: PMC1686779     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  21 in total

1.  An outbreak of leptospirosis in horses on a small farm.

Authors:  S J ROBERTS; C J YORK; J W ROBINSON
Journal:  J Am Vet Med Assoc       Date:  1952-10       Impact factor: 1.936

2.  Immunodiagnosis of leptospiral uveitis in two horses.

Authors:  M G Davidson; M P Nasisse; S M Roberts
Journal:  Equine Vet J       Date:  1987-03       Impact factor: 2.888

3.  Serological diagnosis of leptospirosis in the Province of Quebec.

Authors:  R Higgins; P Cayouette
Journal:  Can Vet J       Date:  1978-01       Impact factor: 1.008

4.  Serologic survey of leptospiral antibodies in horses in California.

Authors:  B B Verma; E L Biberstein; M E Meyer
Journal:  Am J Vet Res       Date:  1977-09       Impact factor: 1.156

5.  Some leptospira agglutinins detected in domestic animals in British Columbia.

Authors:  C E Andress; J Greenfield; K Macdonald
Journal:  Can J Comp Med       Date:  1976-04

6.  Serological studies on leptospirosis in domestic animals in Quebec.

Authors:  R Higgins; P Cayouette; F Hoquet; F De LaSalle
Journal:  Can J Comp Med       Date:  1980-04

7.  Leptospiral infection in horses in Northern Ireland: serological and microbiological findings.

Authors:  W A Ellis; J J O'Brien; J A Cassells; J Montgomery
Journal:  Equine Vet J       Date:  1983-10       Impact factor: 2.888

8.  Diagnosis and prevalence of leptospira infection in aborted and stillborn horses.

Authors:  J M Donahue; B J Smith; K J Redmon; J K Donahue
Journal:  J Vet Diagn Invest       Date:  1991-04       Impact factor: 1.279

9.  Leptospiral infection in aborted equine foetuses.

Authors:  W A Ellis; D G Bryson; J J O'Brien; S D Neill
Journal:  Equine Vet J       Date:  1983-10       Impact factor: 2.888

10.  Leptospira abortion in horses.

Authors:  E C Hodgin; D A Miller; F Lozano
Journal:  J Vet Diagn Invest       Date:  1989-10       Impact factor: 1.279

View more
  3 in total

Review 1.  The role of leptospirosis in reproductive disorders in horses.

Authors:  Camila Hamond; Aline Pinna; Gabriel Martins; Walter Lilenbaum
Journal:  Trop Anim Health Prod       Date:  2013-08-30       Impact factor: 1.559

2.  Seroepidemiologic study of three zoonoses (leptospirosis, Q fever, and tularemia) among trappers in Québec, Canada.

Authors:  B Lévesque; G De Serres; R Higgins; M A D'Halewyn; H Artsob; J Grondin; M Major; M Garvie; B Duval
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

3.  Leptospira seroprevalence and associations between seropositivity, clinical disease and host factors in horses.

Authors:  V Båverud; A Gunnarsson; E Olsson Engvall; P Franzén; A Egenvall
Journal:  Acta Vet Scand       Date:  2009-03-30       Impact factor: 1.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.